INVERNESS MEDICAL INNOVATIONS, INC., as Issuer, the GUARANTORS named herein, as Guarantors, and U.S. BANK NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of May 12, 2009 9.00% Senior Subordinated Notes due 2016Supplemental Indenture • May 12th, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • New York
FIRST SUPPLEMENTAL INDENTURE, dated as of May 12, 2009 (this “Supplemental Indenture”), among Inverness Medical Innovations, Inc., a Delaware corporation, as Issuer (the “Issuer”), each of the Guarantors named herein, as Guarantors, and U.S. Bank National Association, a national banking association, as Trustee (the “Trustee”).
INVERNESS MEDICAL INNOVATIONS, INC., as Issuer, and U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of May 12, 2009Inverness Medical Innovations Inc • May 12th, 2009 • In vitro & in vivo diagnostic substances • New York
INDENTURE dated as of May 12, 2009 between Inverness Medical Innovations, Inc., a Delaware corporation, as Issuer (the “Issuer”), and U.S. BANK NATIONAL ASSOCIATION, as trustee (the “Trustee”).
Inverness Medical Innovations, Inc. $400,000,000 9.00% Senior Subordinated Notes due 2016 UNDERWRITING AGREEMENTUnderwriting Agreement • May 12th, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • New York
UBS SECURITIES LLC GOLDMAN, SACHS & CO. BANC OF AMERICA SECURITIES LLC As Representatives of the several Underwriters c/o UBS SECURITIES LLC 299 Park Avenue New York, New York 10171
